Skip to ContentSkip to Navigation
How to find us A. (Anne-Grete) Märtson


Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients

Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"

Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients

Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)

Epidemic and pandemic viral infections: impact on tuberculosis and the lung

Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis

Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.

Ganciclovir Therapeutic Drug Monitoring: A Case Series

Read more